Sign Up Today and Learn More About Cajal Neuroscience Stock
Invest in or calculate the value of your shares in Cajal Neuroscience or other pre-IPO companies through EquityZen's platform.
Cajal Neuroscience Stock (CAJN)
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
About Cajal Neuroscience Stock
Founded
2020
Headquarters
Seattle, WA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Cajal Neuroscience Press Mentions
Stay in the know about the latest news on Cajal Neuroscience
Cajal Neuro and Creyon Bio join forces on neurodegeneration
longevity • May 20, 2024
Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for ...
globenewswire • May 20, 2024
L-Hydroxyphenylalanine Market Size to Reach 740 million by ...
globenewswire • Jan 20, 2024
NextGen Class of 2024: Top Life Sciences Startups to Watch ...
biospace • Jan 20, 2024
Tech Moves: Absci chief legal officer to depart; Cajal ...
geekwire • Dec 21, 2023
Cajal Neuroscience Management
Leadership team at Cajal Neuroscience
Board Member
Susan Hockfield
Board Member
Robert M. Hershberg
Join now and verify your accreditation status to gain access to:
- Cajal Neuroscience current valuation
- Cajal Neuroscience stock price
- Available deals in Cajal Neuroscience and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cajal Neuroscience stock?
Accredited investors can buy pre-IPO stock in companies like Cajal Neuroscience through EquityZen funds. These investments are made available by existing Cajal Neuroscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cajal Neuroscience stock?
Shareholders can sell their Cajal Neuroscience stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
